Evidence map›Paper›PMID 42395587›Full record

ArticleCureus2026

Rapid Interval Development of a Left Hepatic Artery Pseudoaneurysm During Acute Interstitial Edematous Pancreatitis.

Balakrishna Ravella, Abhinay Theli, Eswar Chand Gadde, Harish Ravipati

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Balakrishna RavellaInternal Medicine, OSF Health St. Mary Medical Center, Galesburg, USA.
Abhinay TheliMedicine, Guthrie Cortland Medical Center, Cortland, USA.
Eswar Chand GaddeInternal Medicine, Ascension St. John Hospital, Tulsa, USA.
Harish RavipatiInternal Medicine, Guthrie Cortland Medical Center, Cortland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visceral artery pseudoaneurysms are uncommon but potentially life-threatening vascular complications of acute pancreatitis. They are most frequently reported in association with necrotizing or chronic pancreatitis and typically develop weeks after disease onset. Hepatic artery pseudoaneurysms are particularly rare. We report a 70-year-old man with presumed idiopathic acute interstitial edematous pancreatitis whose serial contrast-enhanced computed tomography (CT) examinations documented interval development of a left hepatic artery pseudoaneurysm within four days of presentation despite the absence of pancreatic necrosis, pseudocyst formation, or walled-off necrosis. Initial imaging demonstrated uncomplicated interstitial edematous pancreatitis without vascular abnormalities. Repeat imaging obtained because of worsening abdominal pain and abdominal distension revealed a new 2.3 × 2.0 cm enhancing lesion contiguous with the left hepatic artery, highly suspicious for pseudoaneurysm. Shortly after imaging, the patient developed pulseless electrical activity cardiac arrest and died despite prolonged resuscitative efforts. This case broadens the recognized spectrum of pancreatitis-associated vascular complications by demonstrating rapid interval development of a left hepatic artery pseudoaneurysm during acute interstitial edematous pancreatitis without pancreatic necrosis. It also highlights the importance of repeat vascular assessment, preferably with dedicated arterial-phase imaging when feasible, in patients with worsening symptoms or unexpected clinical deterioration.

Indexed as

acute pancreatitishepatic artery pseudoaneurysminterstitial edematous pancreatitisintra-abdominal hemorrhagevascular complication

Identifiers

PMID42395587
PMCPMC13325586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.